search
Back to results

After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet

Primary Purpose

Arthroplasty, Replacement, Knee, Acute Kidney Injury, Tourniquets

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
total knee arthroplasty
Tourniquet limb cuff
Intaarticular lidocain
Sponsored by
Instituto Mexicano del Seguro Social
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Arthroplasty, Replacement, Knee

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients knee arthrosis
  • Required a surgical treatment with Total Knee Arthroplasty

Exclusion Criteria:

  • Not accept to be in the study
  • Not signed consent form
  • Not having blood sample for creatinin meassure

Sites / Locations

  • UMAE Dr. Victorio de La Fuente Narvaez

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

TKA and Tourniquet

Intraarticular lidocain

Arm Description

Total knee arthroplasty and use of tourniquet limb cuff at 270 mmHg

Total knee arthroplasty with Intaarticular lidocain

Outcomes

Primary Outcome Measures

Creatinin before surgery
Blood Creatinin meassure in mg/dl before surgery
Creatinin after surgery 1
Blood Creatinin meassure in mg/dl at 24 hours
Creatinin after surgery 2
Blood Creatinin meassure in mg/dl at 48 hours

Secondary Outcome Measures

Full Information

First Posted
December 26, 2018
Last Updated
January 7, 2019
Sponsor
Instituto Mexicano del Seguro Social
search

1. Study Identification

Unique Protocol Identification Number
NCT03795805
Brief Title
After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet
Official Title
After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
March 15, 2018 (Actual)
Primary Completion Date
November 20, 2018 (Actual)
Study Completion Date
December 20, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Mexicano del Seguro Social

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study analize the incidence of acute renal failure after performing total knee arthroplasty with or without use of tourniquet limb cuff (half of patients for each group) in a randomized clinical trial
Detailed Description
This study analize the incidence of acute renal failure after performing total knee arthroplasty with or without (using local intraarticular anesthesia) use of tourniquet limb cuff (half of patients for each group) in a randomized clinical trial

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthroplasty, Replacement, Knee, Acute Kidney Injury, Tourniquets, Knee Osteoarthritis

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Clinical Trial
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TKA and Tourniquet
Arm Type
Other
Arm Description
Total knee arthroplasty and use of tourniquet limb cuff at 270 mmHg
Arm Title
Intraarticular lidocain
Arm Type
Experimental
Arm Description
Total knee arthroplasty with Intaarticular lidocain
Intervention Type
Procedure
Intervention Name(s)
total knee arthroplasty
Other Intervention Name(s)
TKA
Intervention Description
Total knee arhroplasty
Intervention Type
Procedure
Intervention Name(s)
Tourniquet limb cuff
Intervention Description
Tourniquet limb cuff and regular anesthesia
Intervention Type
Drug
Intervention Name(s)
Intaarticular lidocain
Other Intervention Name(s)
lidocaine
Intervention Description
20 ml of 2% lidocain application intraarticular before surgery (intraarticular lidocain)
Primary Outcome Measure Information:
Title
Creatinin before surgery
Description
Blood Creatinin meassure in mg/dl before surgery
Time Frame
Creatinin before surgery
Title
Creatinin after surgery 1
Description
Blood Creatinin meassure in mg/dl at 24 hours
Time Frame
Creatinin after surgery 1 at 24 hours
Title
Creatinin after surgery 2
Description
Blood Creatinin meassure in mg/dl at 48 hours
Time Frame
Creatinin after surgery 2 at 48 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients knee arthrosis Required a surgical treatment with Total Knee Arthroplasty Exclusion Criteria: Not accept to be in the study Not signed consent form Not having blood sample for creatinin meassure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Avelino Colin Vázquez, MD
Organizational Affiliation
IMSS
Official's Role
Principal Investigator
Facility Information:
Facility Name
UMAE Dr. Victorio de La Fuente Narvaez
City
Ciudad de México
ZIP/Postal Code
07020
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
We will share only de demographic data and trial results

Learn more about this trial

After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet

We'll reach out to this number within 24 hrs